Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Eisai
Pharma
Roche, Eisai, Takeda and more—Fierce Pharma Asia
Roche and Eisai each bought a HER2 drug from separate Chinese biotechs. Takeda will lay off 186 staffers across Massachusetts. Plus more.
Angus Liu
May 12, 2023 9:15am
Biogen's Alzheimer's sales are negative early in Leqembi launch
Apr 25, 2023 11:40am
J&J-Legend, BeiGene-Novartis and more—Fierce Pharma Asia
Apr 21, 2023 9:15am
Eisai helps build a head and neck cancer community
Apr 17, 2023 7:30am
Takeda, Astellas, Eisai—Fierce Pharma Asia
Apr 14, 2023 8:25am
Eisai's Leqembi gaining ground with US neurologists
Apr 11, 2023 10:00am
